📣 Hot off the press! Access our latest white paper, Implications of New European Union Regulations on Advanced Therapy Medicinal Products: alirahealth.com/education-hub/… #ATMPs #HTAR #EUPharmaPackage

Earlier this year we shared three key trends in surgical #robotics that will change orthopedic procedures in 2024. Are you seeing these trends, as well as the challenges and opportunities, in your role? Start here: alirahealth.com/education-hub/… #RAS #orthopedics #HTAi2024Seville

Research into #lupus patient experience, treatment patterns, and long-term clinical outcomes is challenging. Learn more about our commitment to accelerating solutions for lupus patients, and connect with our experts onsite at #EULAR2024: alirahealth.com/lupus/ #rheumatology

#Realworlddata provides insight into the effectiveness, safety, and usage of new treatments. Learn more about the vital role of #RWD in the development of #lupus solutions and connect with our experts onsite this week at #EULAR2024: alirahealth.com/education-hub/… #RWE

🌷 If you're in Amsterdam for #PSI2024, take this opportunity to meet our #biometrics experts and discover our solutions that prioritize data, the key asset to maximize insights, increase quality and access, and decrease reporting timelines.

We're proud to announce our collaboration with the Scottsdale Research Institute to provide comprehensive regulatory and clinical support with the goal to bring clinical research of psilocybin to Arizona. Press release: alirahealth.com/education-hub/… #clinicalstudies #clinicaltrials

Have you downloaded our guide to creating patient-centric #clinicaltrials in #raredisease? alirahealth.com/education-hub/… #patientengagement #rarediseases

You've decided you need a patient advisory board (PAB) - now what? Here's how to optimize your clinical research with PABs: alirahealth.com/education-hub/… #patientengagement #patientvoice #patientcentricity

In this case study, our #patientengagement team dove into the patient perspective with a cross functional approach that converted patient data into valuable strategic insights for our client. Start reading: alirahealth.com/education-hub/… #patientvoice #patientcentricity #pharma

The regulatory landscape for #medtech in the EU is complex, continuously evolving, and challenging to navigate. Assess your readiness for the transition to Medical Device Regulation with this preparedness checklist: alirahealth.com/education-hub/… #medicaldevices #MDR

Take a sneak peek inside our recent white paper on considerations for commercialization of cell and gene therapies outside of non-orphan indications: alirahealth.com/education-hub/… #CGTs #advancedtherapies #drugdevelopment

Experts Giuseppe Gulotta and Catia Proenca answer your frequently asked questions about the opportunity for RWE to impact market access for rare diseases: alirahealth.com/education-hub/… #rwe #marketaccess #rarediseases

Our cross functional team of clinical, regulatory, pricing and access experts can support you on the complex journey of radiopharmaceutical solution development. Learn how: alirahealth.com/nuclear-medici… #NuclearMedicine #radiopharma

Visit our Scientific Articles section for publications covering biometrics, wound care, rare diseases, real-world evidence, value-based contracts and more. Start here: alirahealth.com/scientific-art… #clinicalresearch #rwe

Subscribe to RWE Decision Alerts: alirahealth.com/rwe-decision-a… What are #RWE Decision Alerts? Email alerts providing subscribers with timely analyses of published reports from HAS/AEMPS/NICE/EMA/FDA where #realworldevidence is used to support HTA and regulatory decision-making.

What are the benefits of systematic and consistent #patientengagement? Expert Giulia Pierini explains: alirahealth.com/education-hub/… #patientvoice #patientcentricity

Get this white paper to learn about challenges in access and commercialization of advanced therapies medicinal products: alirahealth.com/education-hub/… #ATMPs #advancedtherapies

Read our latest case study to discover why our market access and oncology expertise and robust experience in building early payer value stories won us this project: alirahealth.com/education-hub/… #oncology #radiopharma

Our pharma client sought support to evaluate and leverage the data generated from a US trial in other markets and develop a mitigation plan for gaps in evidence. Start reading our latest case study: alirahealth.com/education-hub/… #radiopharma #oncology

Introducing our 2024 Bronze sponsors for the #WorldOrphanDrugCongress ! 🏢AliraHealth 🏢#CascadorHealth 🏢#GeneScape 🏢#MedBioInformatics These companies offer expertise from medical data to patient modelling to support the orphan drug industry.